BKM-1740

N/A

Report date: 2025/01/26 18:52:09
NME

Base Information

Drug NameBKM-1740
Drug Alias NameBKM-1740
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBaculoviral IAP repeat-containing protein 5 inhibitorsBradykinin receptors antagonists
TargetsBradykinin receptorsBaculoviral IAP repeat-containing protein 5
Therapy Area/IndicationsBone metastasesProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Colorado System
China Registration ClassN/A

Develop Information

Active CompaniesMetCure Therapeutics LLC
Inactive CompaniesUniversity Of Colorado System
Active IndicationsBone metastases
Inactive IndicationsProstatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A